These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 15806300

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Triiodothyronine, thyroxine, and iodine in purified thyroglobulin from patients with Graves' disease.
    Izumi M, Larsen PR.
    J Clin Invest; 1977 Jun; 59(6):1105-12. PubMed ID: 577211
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Iodide, cytokines and TSH-receptor expression in Graves' disease.
    Schuppert F, Hiller W, Weinland G, Hoang-Vu C, von zur Mühlen A, Kohn LD.
    Exp Clin Endocrinol Diabetes; 1996 Jun; 104 Suppl 4():68-74. PubMed ID: 8981006
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The thioredoxin-thioredoxin reductase system: over-expression in human cancer.
    Lincoln DT, Ali Emadi EM, Tonissen KF, Clarke FM.
    Anticancer Res; 2003 Jun; 23(3B):2425-33. PubMed ID: 12894524
    [Abstract] [Full Text] [Related]

  • 9. A predictive mathematical model for the calculation of the final mass of Graves' disease thyroids treated with 131I.
    Traino AC, Di Martino F, Grosso M, Monzani F, Dardano A, Caraccio N, Mariani G, Lazzeri M.
    Phys Med Biol; 2005 May 07; 50(9):2181-91. PubMed ID: 15843745
    [Abstract] [Full Text] [Related]

  • 10. Detection of the novel autoantibody (anti-UACA antibody) in patients with Graves' disease.
    Ohkura T, Taniguchi S, Yamada K, Nishio N, Okamura T, Yoshida A, Kamijou K, Fukata S, Kuma K, Inoue Y, Hisatome I, Senju S, Nishimura Y, Shigemasa C.
    Biochem Biophys Res Commun; 2004 Aug 20; 321(2):432-40. PubMed ID: 15358194
    [Abstract] [Full Text] [Related]

  • 11. Spiking expression of mu-crystallin mRNA during treatment with methimazole in patients with graves' hyperthyroidism.
    Suzuki S, Takei M, Nishio S, Inaba H, Sato A, Yamazaki M, Shinomiya K, Hashizume K.
    Horm Metab Res; 2009 Jul 20; 41(7):548-53. PubMed ID: 19280551
    [Abstract] [Full Text] [Related]

  • 12. Treatment outcome of Graves' disease in Thai children.
    Somnuke PH, Pusuwan P, Likitmaskul S, Santiprabhob J, Sawathiparnich P.
    J Med Assoc Thai; 2007 Sep 20; 90(9):1815-20. PubMed ID: 17957924
    [Abstract] [Full Text] [Related]

  • 13. High redox thioredoxin but low thioredoxin reductase activities in the serum of patients with rheumatoid arthritis.
    Lemarechal H, Allanore Y, Chenevier-Gobeaux C, Ekindjian OG, Kahan A, Borderie D.
    Clin Chim Acta; 2006 May 20; 367(1-2):156-61. PubMed ID: 16458876
    [Abstract] [Full Text] [Related]

  • 14. Serum levels of the interferon-gamma-inducible alpha chemokine CXCL10 in patients with active Graves' disease, and modulation by methimazole therapy and thyroidectomy.
    Antonelli A, Fallahi P, Rotondi M, Ferrari SM, Serio M, Miccoli P.
    Br J Surg; 2006 Oct 20; 93(10):1226-31. PubMed ID: 16838393
    [Abstract] [Full Text] [Related]

  • 15. Thyroid cancer yield in patients with Graves' disease.
    Stocker DJ, Burch HB.
    Minerva Endocrinol; 2003 Sep 20; 28(3):205-12. PubMed ID: 14605602
    [Abstract] [Full Text] [Related]

  • 16. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells.
    Goto Y, Itoh M, Ohta Y, Ogawa N, Goto Y, Ohashi H.
    Thyroid; 1997 Aug 20; 7(4):567-73. PubMed ID: 9292944
    [Abstract] [Full Text] [Related]

  • 17. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
    Bossowski A, Czarnocka B, Bardadin K, Stasiak-Barmuta A, Urban M, Dadan J, Ratomski K, Bossowska A.
    Autoimmunity; 2008 Mar 20; 41(2):163-73. PubMed ID: 18324486
    [Abstract] [Full Text] [Related]

  • 18. Administration of additional inactive iodide during radioiodine therapy for Graves' disease: who might benefit?
    Dietlein M, Moka D, Reinholz U, Schmidt M, Schomäcker K, Schicha H, Wellner U.
    Nuklearmedizin; 2007 Mar 20; 46(3):77-84. PubMed ID: 17549318
    [Abstract] [Full Text] [Related]

  • 19. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I, Sierocinska-Sawa J, Szewczyk L, Korobowicz E.
    Horm Res; 2009 Mar 20; 71(6):350-8. PubMed ID: 19506393
    [Abstract] [Full Text] [Related]

  • 20. Expression of Bcl-2 family proteins in thyrocytes from young patients with immune and nonimmune thyroid diseases.
    Bossowski A, Czarnocka B, Bardadin K, Urban M, Niedziela M, Dadan J.
    Horm Res; 2008 Mar 20; 70(3):155-64. PubMed ID: 18663316
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.